T1	CHEM 11 30	esteroles vegetales
#1	AnnotatorNotes T1	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T2	PROC 51 72	colesterol plasmático
#2	AnnotatorNotes T2	C0858034; Plasma Cholesterol Test; Laboratory Procedure
T3	PROC 979 1034	Se analizaron la composición corporal, hábitos de salud
T4	PROC 74 137	ensayo clínico, controlado, aleatorizado, cruzado y doble ciego
#3	AnnotatorNotes T4	C0150097; Cross-Over Studies; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity
T5	PROC 958 977	muestras sanguíneas
#4	AnnotatorNotes T5	C1277698; Blood sample taken; Laboratory Procedure
T6	DISO 156 175	hipercolesterolemia
#5	AnnotatorNotes T6	C0020443; Hypercholesterolemia; Disease or Syndrome
T7	DISO 227 252	enfermedad cardiovascular
#6	AnnotatorNotes T7	C0007222; Cardiovascular Diseases; Disease or Syndrome
T8	CHEM 258 277	esteroles vegetales
#7	AnnotatorNotes T8	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T9	PROC 1075 1104	perfil lipídico, hematológico
T10	CHEM 397 416	esteroles vegetales
#8	AnnotatorNotes T10	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T11	PROC 459 480	colesterol plasmático
#9	AnnotatorNotes T11	C0858034; Plasma Cholesterol Test; Laboratory Procedure
T12	PROC 511 574	ensayo clínico, controlado, aleatorizado, doble ciego y cruzado
#10	AnnotatorNotes T12	C0150097; Cross-Over Studies; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity
T13	CHEM 580 589	esteroles
#11	AnnotatorNotes T13	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T14	CHEM 871 880	esteroles
#12	AnnotatorNotes T14	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T15	PROC 931 943	intervención
#13	AnnotatorNotes T15	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T16	ANAT 967 977	sanguíneas
#14	AnnotatorNotes T16	C0005767; Blood; Body Substance
T17	ANAT 1063 1073	sanguíneos
#15	AnnotatorNotes T17	C0005767; Blood; Body Substance
T18	CHEM 1082 1090	lipídico
#16	AnnotatorNotes T18	C0023779; Lipids; Organic Chemical
T19	DISO 1106 1117	inflamación
#17	AnnotatorNotes T19	C0021368; Inflammation; Pathologic Function
T20	CHEM 1288 1298	colesterol
#18	AnnotatorNotes T20	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T21	CHEM 1627 1646	esteroles vegetales
#19	AnnotatorNotes T21	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T22	PROC 1727 1766	estrategia terapéutica no farmacológica
T23	DISO 1789 1808	hipercolesterolemia
#20	AnnotatorNotes T23	C0020443; Hypercholesterolemia; Disease or Syndrome
T24	CHEM 51 61	colesterol
#21	AnnotatorNotes T24	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T25	ANAT 62 72	plasmático
#22	AnnotatorNotes T25	C0032105; Plasma; Body Substance
T26	ANAT 238 252	cardiovascular
#23	AnnotatorNotes T26	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T27	CHEM 459 469	colesterol
#24	AnnotatorNotes T27	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T28	ANAT 470 480	plasmático
#25	AnnotatorNotes T28	C0032105; Plasma; Body Substance
T29	ANAT 1008 1016	corporal
#26	AnnotatorNotes T29	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T30	PROC 1288 1304	colesterol total
#27	AnnotatorNotes T30	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T31	PROC 1306 1320	colesterol-LDL
#28	AnnotatorNotes T31	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T32	PROC 1322 1336	colesterol-HDL
#29	AnnotatorNotes T32	C0392885; High density lipoprotein measurement; Laboratory Procedure
T33	PROC 1338 1351	triglicéridos
#30	AnnotatorNotes T33	C0202236; Triglycerides measurement; Laboratory Procedure
T34	PROC 1354 1371	colesterol no-HDL
#31	AnnotatorNotes T34	C1535899; Non-High Density Lipoprotein Cholesterol Measurement; Laboratory Procedure
T35	PROC 1595 1608	triglicéridos
#32	AnnotatorNotes T35	C0202236; Triglycerides measurement; Laboratory Procedure
T36	Spec_cue 214 220	riesgo
T38	LIVB 484 499	adultos jóvenes
#33	AnnotatorNotes T38	C0238598; Young Adult; Age Group
T40	Dose 591 597	2,24 g
T41	Frequency 598 605	diarios
T43	Duration 693 718	dos periodos de 3 semanas
T44	Duration 758 767	2 semanas
T45	LIVB 775 793	grupo experimental
#34	AnnotatorNotes T45	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T46	LIVB 798 811	grupo control
#35	AnnotatorNotes T46	C0009932; Control Groups; Group
T47	Neg_cue 867 870	sin
T49	LIVB 1154 1162	personas
#36	AnnotatorNotes T49	C0027361; Persons; Population Group
T50	Age 1199 1214	38,8 ± 7,3 años
T51	LIVB 1502 1520	grupo experimental
#37	AnnotatorNotes T51	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T52	LIVB 1526 1539	grupo control
#38	AnnotatorNotes T52	C0009932; Control Groups; Group
A1	Assertion T7 Speculated
A2	Population_data T38 Age
A3	Assertion T14 Negated
R1	Negation Arg1:T47 Arg2:T14	
R2	Speculation Arg1:T36 Arg2:T7	
T37	Neg_cue 1750 1752	no
T39	Quantifier_or_Qualifier 1753 1766	farmacológica
A4	Assertion T39 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T39	
R4	Negation Arg1:T37 Arg2:T39	
T42	Neg_cue 1365 1367	no
T48	CHEM 1368 1371	HDL
A5	Assertion T48 Negated
#39	AnnotatorNotes T48	C0023821; High Density Lipoproteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
R5	Negation Arg1:T42 Arg2:T48	
T53	Observation 1 7	Efecto
#40	AnnotatorNotes T53	C1518681; Outcome of Therapy; Finding (?)
R6	Causes Arg1:T1 Arg2:T53	
T54	Observation 37 72	reducción del colesterol plasmático
R7	Location_of Arg1:T25 Arg2:T2	
R10	Causes Arg1:T1 Arg2:T54	
R11	Before Arg1:T6 Arg2:T7	
R12	Location_of Arg1:T26 Arg2:T7	
T55	Observation 383 389	efecto
#41	AnnotatorNotes T55	C1518681; Outcome of Therapy; Finding (?)
R13	Causes Arg1:T10 Arg2:T55	
R14	Location_of Arg1:T28 Arg2:T11	
R15	Experiences Arg1:T38 Arg2:T11	
R16	Experiences Arg1:T38 Arg2:T55	
R17	Experiences Arg1:T38 Arg2:T10	
R18	Before Arg1:T10 Arg2:T11	
T56	Food 433 438	leche
#42	AnnotatorNotes T56	C2825079; Milk - dietary; Food
R19	Combined_with Arg1:T10 Arg2:T56	
T57	Observation 445 480	reducción del colesterol plasmático
R20	Location_of Arg1:T28 Arg2:T57	
R22	Experiences Arg1:T38 Arg2:T57	
R23	Has_Frequency Arg1:T13 Arg2:T41	
R24	Has_Dose_or_Strength Arg1:T13 Arg2:T40	
T58	Quantifier_or_Qualifier 631 640	dos tomas
T59	Food 658 663;674 683	leche desnatada
#43	AnnotatorNotes T59	C0349375; skim milk; Food
R25	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T58	
R26	Combined_with Arg1:T13 Arg2:T59	
R27	Has_Duration_or_Interval Arg1:T13 Arg2:T43	
T60	CONC 739 753	fase de lavado
#44	AnnotatorNotes T60	C1710661; Washout Period; Temporal Concept
R28	Has_Duration_or_Interval Arg1:T60 Arg2:T44	
R29	Before Arg1:T13 Arg2:T60	
R30	Experiences Arg1:T45 Arg2:T13	
T61	Food 850 865	leche desnatada
#45	AnnotatorNotes T61	C1710661; Washout Period; Temporal Concept
R31	Experiences Arg1:T46 Arg2:T61	
R32	Combined_with Arg1:T61 Arg2:T14	
T62	CONC 903 943	al final de cada periodo de intervención
T63	CONC 888 897;912 943	al inicio de cada periodo de intervención
R33	Overlap Arg1:T5 Arg2:T63	
R34	Overlap Arg1:T5 Arg2:T62	
R35	Location_of Arg1:T29 Arg2:T3	
R36	Location_of Arg1:T17 Arg2:T9	
R37	Has_Age Arg1:T49 Arg2:T50	
T64	Quantifier_or_Qualifier 1262 1269	basales
#46	AnnotatorNotes T64	C1442488; Baseline; Quantitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T64	
R39	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T64	
R40	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T64	
R41	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T64	
R42	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T64	
T65	Quantifier_or_Qualifier 1272 1279	finales
#47	AnnotatorNotes T65	C3853528; Final; Temporal Concept
R43	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T65	
R44	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T65	
R45	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T65	
R46	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T65	
R47	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T65	
R48	Experiences Arg1:T51 Arg2:T35	
R49	Experiences Arg1:T52 Arg2:T35	
T66	Food 1667 1675	alimento
#48	AnnotatorNotes T66	C0016452; Food; Food
R50	Combined_with Arg1:T21 Arg2:T66	
T67	Food 1705 1710	leche
#49	AnnotatorNotes T67	C2825079; Milk - dietary; Food
R51	Combined_with Arg1:T21 Arg2:T67	
R52	Used_for Arg1:T21 Arg2:T22	
T68	Observation 202 220	factores de riesgo
#50	AnnotatorNotes T68	C0035648; risk factors; Finding
#51	AnnotatorNotes T39	C0205464; pharmacological; Functional Concept
A6	Experiencer T38 Patient
A7	Experiencer T45 Patient
A8	Experiencer T46 Patient
A9	Experiencer T49 Patient
A10	Experiencer T51 Patient
A11	Experiencer T52 Patient
R9	Has_Result_or_Value Arg1:T2 Arg2:T54	
R8	Has_Result_or_Value Arg1:T11 Arg2:T57	
